SPDR S&P Biotech ETF (NYSEARCA:XBI) Stock Holdings Increased by Arlington Financial Advisors LLC

Arlington Financial Advisors LLC raised its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 201.4% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 41,783 shares of the exchange traded fund’s stock after acquiring an additional 27,920 shares during the period. Arlington Financial Advisors LLC owned approximately 0.05% of SPDR S&P Biotech ETF worth $3,965,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in XBI. Concourse Financial Group Securities Inc. raised its stake in shares of SPDR S&P Biotech ETF by 21.2% in the 4th quarter. Concourse Financial Group Securities Inc. now owns 658 shares of the exchange traded fund’s stock worth $59,000 after buying an additional 115 shares in the last quarter. Verity Asset Management Inc. raised its stake in shares of SPDR S&P Biotech ETF by 0.8% in the 4th quarter. Verity Asset Management Inc. now owns 17,368 shares of the exchange traded fund’s stock worth $1,551,000 after buying an additional 140 shares in the last quarter. Greenwich Wealth Management LLC raised its stake in shares of SPDR S&P Biotech ETF by 1.4% in the 4th quarter. Greenwich Wealth Management LLC now owns 11,451 shares of the exchange traded fund’s stock worth $1,022,000 after buying an additional 155 shares in the last quarter. Mesirow Institutional Investment Management Inc. raised its stake in shares of SPDR S&P Biotech ETF by 3.2% in the 4th quarter. Mesirow Institutional Investment Management Inc. now owns 5,565 shares of the exchange traded fund’s stock worth $497,000 after buying an additional 170 shares in the last quarter. Finally, HB Wealth Management LLC grew its holdings in shares of SPDR S&P Biotech ETF by 4.9% in the 4th quarter. HB Wealth Management LLC now owns 4,280 shares of the exchange traded fund’s stock worth $382,000 after acquiring an additional 200 shares during the last quarter.

SPDR S&P Biotech ETF Trading Down 0.2 %

Shares of NYSEARCA XBI traded down $0.15 during mid-day trading on Friday, reaching $92.71. The company had a trading volume of 7,872,582 shares, compared to its average volume of 10,728,328. The stock has a market cap of $7.07 billion, a PE ratio of 11.47 and a beta of 1.11. The company has a 50-day moving average price of $89.95 and a two-hundred day moving average price of $90.80. SPDR S&P Biotech ETF has a 1-year low of $63.80 and a 1-year high of $103.52.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.